Literature DB >> 1091704

Chemotaxis of basophils by lymphocyte-dependent and lymphocyte-independent mechanisms.

P A Ward, H F Dvorak, S Cohen, T Yoshida, R Data, S S Selvaggio.   

Abstract

Guine pigs basophils obtained from blood or bone marrow have been studied for their chemotactic responsiveness. Chemotactic factors for basophils include a substance (lymphokine) present in culture fluids from antigen-stimulated lymphocytes, a material generated in zymosan-activated guinea pig serum, a C5 cleavage factor, and a bacterial factor. When compared with homologous neutrophils and monocytes, basophils respond most rapidly to a chemotactic stimulus. The lymphokine basophil chemotactic factor is physicochemically similar to the previously described monocyte chemotactic factor but appears to be distinct from it as well as MIF and neutrophil chemotactic factor present in the same fluids, Part of the evidence for this is the ability to detect basophil chemotactic factor in the absence of other lymphokine activities under appropriate experimental conditions. More evidence, specifically relating to the monocyte factor, is that monocytes can adsorb basophil chemotactic activity but not vice versa. This latter observation may have implications for the mechanism whereby the accumulation of basophils is controlled and limited in vivo. In addition, it was noted that specific antigen could also suppress basophil chemotaxis. Although the mechanism of this phenomenon is unclear, it could serve as a second means by which basophil accumulation may be controlled in the intact animal. Taken together, these observations provide further definition of the chemotactic behavior of basophils in general, and underscore some of the ways in which lymphocytes can influence basophils through lymphokine-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091704

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Immunology of interactions between ticks and laboratory animals.

Authors:  J R Allen
Journal:  Exp Appl Acarol       Date:  1989-06       Impact factor: 2.132

2.  Granulocytes (the red, white, and blue) in hypersensitivity reactions: A review.

Authors:  H F Dvorak; S Cohen; P A Ward
Journal:  Inflammation       Date:  1976-03       Impact factor: 4.092

3.  Relationship between the tuberculin-type and Jones-Mote-type hypersensitivities: suppression of basophil infiltration by mycobacterial adjuvant.

Authors:  S Nakamura; H Sanui; K Nomoto
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

4.  Immunohistochemical analysis of contact sensitivity reactions in the guinea-pig using novel monoclonal antibodies: the influence of topical cyclosporin A.

Authors:  S N Payne; A W Thomson
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

5.  Serum basophil-stimulating activity in the guinea-pig during induction of basophilic responses to ovalbumin and tick feeding.

Authors:  J A Denburg; P W Askenase; S J Brown; J Bienenstock
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

Review 6.  Basophils in human disease.

Authors:  E B Mitchell; P W Askenase
Journal:  Clin Rev Allergy       Date:  1983-09

7.  Basophils in tuberculin and "Jones-Mote" delayed reactions of humans.

Authors:  P W Askenase; J E Atwood
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

8.  Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.

Authors:  R Huey; C M Bloor; M S Kawahara; T E Hugli
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

9.  Histology of bovine skin reactions to Ixodes holocyclus Neumann.

Authors:  J R Allen; B M Doube; D H Kemp
Journal:  Can J Comp Med       Date:  1977-01

10.  Basophil hypersensitivity response in rabbits.

Authors:  J M Clark; G Altman; F B Fromowitz
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.